Not applicableLooking for participantsNCT06117384What this trial is testingSystems Oncology Approach to Optimize Ovarian Cancer TreatmentWho this might be right forOvarian Cancer University of Helsinki 500
Not applicableStudy completedNCT03367247What this trial is testingBOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and RenewalWho this might be right forGynecologic CancerGastrointestinal Cancer Dana-Farber Cancer Institute 121
Not applicableEnrolling By InvitationNCT07078409What this trial is testingClinician Nudge to Referral of Adnexal Masses to Gynecologic OncologyWho this might be right forOvarian Cancer Abramson Cancer Center at Penn Medicine 240
Large-scale testing (Phase 3)Ended earlyNCT05329545What this trial is testingUpifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)Who this might be right forHigh Grade Serous Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer Mersana Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT00253539What this trial is testingArzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast CancerWho this might be right forBreast CancerHereditary Breast/Ovarian Cancer (brca1, brca2) The Cleveland Clinic 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT07096583What this trial is testingAn Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian CancerWho this might be right forOvary Cancer Anhui Provincial Cancer Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00107445What this trial is testingEF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial CancerWho this might be right forPrimary Peritoneal Cavity CancerStage I Endometrial CarcinomaStage I Ovarian Epithelial Cancer+13 more National Cancer Institute (NCI) 60
Not applicableNot Yet RecruitingNCT06726330What this trial is testingRisk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic CancerWho this might be right forTubo-ovarian CarcinomaHigh-grade Serous CarcinomaPrimary Peritoneal Carcinoma Stage III+2 more Centre Oscar Lambret 1,100
Testing effectiveness (Phase 2)Ended earlyNCT05256381What this trial is testingSOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid TumorsWho this might be right forNon-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more SOTIO Biotech AG 166
Testing effectiveness (Phase 2)Looking for participantsNCT05231122What this trial is testingPembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian CancerWho this might be right forOvarian Clear Cell AdenocarcinomaPlatinum-Sensitive Ovarian CarcinomaRecurrent Endometrial Serous Adenocarcinoma+12 more Roswell Park Cancer Institute 80
Early research (Phase 1)Study completedNCT02081495What this trial is testingDOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerWho this might be right forNeoplasms Janssen Research & Development, LLC 35
Not applicableStudy completedNCT04626895What this trial is testingEfficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN CancersWho this might be right forBreast CancerOvarian CancerGynecologic Neoplasm+1 more Medstar Health Research Institute 15
Early research (Phase 1)Active Not RecruitingNCT03017131What this trial is testingGenetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma Roswell Park Cancer Institute 9
Not applicableStudy completedNCT03471572What this trial is testingStudy to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in IndiaWho this might be right forOvarian Cancer AstraZeneca 240
Not applicableUnknownNCT03979339What this trial is testingFeasibility of a New Technology for Isolating Circulating Tumour CellsWho this might be right forHER2-positive Metastatic Breast CancerOvarian CancerHormone-resistant Prostate Cancer+1 more Centre Oscar Lambret 76
Not applicableLooking for participantsNCT06378905What this trial is testingCukurova Score Validation StudyWho this might be right forEpithelial Ovarian CancerPrimary Cytoreduction Cukurova University 130
Testing effectiveness (Phase 2)Ended earlyNCT02923739What this trial is testingPaclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+17 more M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)UnknownNCT00838656What this trial is testingTwo Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Warwick Medical School 88
Early research (Phase 1)Active Not RecruitingNCT03860272What this trial is testingFc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerWho this might be right forAdvanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more Agenus Inc. 499
Testing effectiveness (Phase 2)Ended earlyNCT04999605What this trial is testingAK112 Combined With PARP Inhibitor in the Treatment of Recurrent Ovarian CancerWho this might be right forOvarian NeoplasmsRecurrent Ovarian CarcinomaRelapsed Ovarian Cancer+1 more Akeso 8